Quick Takeaways
- Forest Baskett has 20 issuer positions tracked on this page.
- Estimated disclosed ownership value: $381,470,514.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Forest Baskett
- Location
- Menlo Park, CA
- Summary
- The estimated net worth of Forest Baskett is at least $381,470,514 dollars as of 12 Mar 2026. Forest Baskett is the 10%+ Owner of Monte Rosa Therapeutics, Inc. and owns shares of Monte Rosa Therapeutics, Inc. (GLUE) stock worth about $146.15M. Forest Baskett is the 10%+ Owner of Savara Inc and owns shares of Savara Inc (SVRA) stock worth about $108.9M. Forest Baskett is the 10%+ Owner of MBX Biosciences, Inc. and owns shares of MBX Biosciences, Inc. (MBX) stock worth about $38.64M. Forest Baskett is the 10%+ Owner of SpyGlass Pharma, Inc. and owns shares of SpyGlass Pharma, Inc. (SGP) stock worth about $37.77M. Forest Baskett is the 10%+ Owner of Trevi Therapeutics, Inc. and owns shares of Trevi Therapeutics, Inc. (TRVI) stock worth about $16.81M. Forest Baskett is the 10%+ Owner of ARDELYX, INC. and owns shares of ARDELYX, INC. (ARDX) stock worth about $15M. Forest Baskett is the 10%+ Owner of Korro Bio, Inc. and owns shares of Korro Bio, Inc. (KRRO) stock worth about $14.42M. Forest Baskett is the 10%+ Owner of Coursera, Inc. and owns shares of Coursera, Inc. (COUR) stock worth about $1.85M. Forest Baskett is the 10%+ Owner of Metacrine, Inc. and owns shares of Metacrine, Inc. stock worth about $1.2M. Forest Baskett is the Director of Robinhood Markets, Inc. and owns shares of Robinhood Markets, Inc. (HOOD) stock worth about $450.7K. Forest Baskett is the 10%+ Owner of IonQ, Inc. and owns shares of IonQ, Inc. (IONQ) stock worth about $125.9K. Forest Baskett is the 10%+ Owner of AVEO PHARMACEUTICALS, INC. and owns shares of AVEO PHARMACEUTICALS, INC. stock worth about $48.3K. Forest Baskett is the 10%+ Owner of Sagimet Biosciences Inc. and owns shares of Sagimet Biosciences Inc. (SGMT) stock worth about $46.3K. Forest Baskett is the 10%+ Owner of Mirum Pharmaceuticals, Inc. and owns shares of Mirum Pharmaceuticals, Inc. (MIRM) stock worth about $43.4K. Forest Baskett is the 10%+ Owner of Desktop Metal, Inc. and owns shares of Desktop Metal, Inc. stock worth about $5.4K. Forest Baskett is the 10%+ Owner of Eargo, Inc. and owns shares of Eargo, Inc. stock worth about $4.2K.
- Signature
- /s/ Zachary Bambach, attorney-in-fact
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Forest Baskett and return when a new Insider Trading filing appears.
This tracks SEC filing changes for this page using existing product update flows.
What Changed
- Largest disclosed position: Monte Rosa Therapeutics, Inc. ($146,153,662).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Official SEC Source
Filed on Form 4
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
See Original FilingOwnership of Forest Baskett
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| GLUE | Monte Rosa Therapeutics, Inc. | 10%+ Owner | $146,153,662 | 28 Jun 2021 | ||
| SVRA | Savara Inc | 10%+ Owner | $108,897,125 | 17 Jul 2023 | ||
| MBX | MBX Biosciences, Inc. | 10%+ Owner | $38,638,855 | 16 Sep 2024 | ||
| SGP | SpyGlass Pharma, Inc. | 10%+ Owner | $37,772,629 | 09 Feb 2026 | ||
| TRVI | Trevi Therapeutics, Inc. | 10%+ Owner | $16,814,393 | 31 Dec 2025 | ||
| ARDX | ARDELYX, INC. | 10%+ Owner | $14,998,764 | 09 Dec 2021 | ||
| KRRO | Korro Bio, Inc. | 10%+ Owner | $14,419,591 | +$2,300,881 | +19% | 10 Mar 2026 |
| COUR | Coursera, Inc. | 10%+ Owner | $1,846,623 | 15 Feb 2023 | ||
| MTCR | Metacrine, Inc. | 10%+ Owner | $1,204,731 | 10 Dec 2021 | ||
| HOOD | Robinhood Markets, Inc. | Director | $450,661 | 02 May 2022 | ||
| IONQ, IONQ-WT | IonQ, Inc. | 10%+ Owner | $125,856 | 16 Nov 2022 | ||
| AVEO | AVEO PHARMACEUTICALS, INC. | 10%+ Owner | $48,300 | 19 Oct 2022 | ||
| SGMT | Sagimet Biosciences Inc. | 10%+ Owner | $46,330 | 29 Jan 2024 | ||
| MIRM | Mirum Pharmaceuticals, Inc. | 10%+ Owner | $43,398 | 13 Jun 2023 | ||
| DM | Desktop Metal, Inc. | 10%+ Owner | $5,377 | 08 Jun 2021 | ||
| EAR | Eargo, Inc. | 10%+ Owner | $4,219 | 24 May 2021 | ||
| NEUE | NeueHealth, Inc. | Director, 10%+ Owner | $0 | -$5,670 | -100% | 02 Oct 2025 |
| AKUS | Akouos, Inc. | 10%+ Owner | 30 Nov 2022 | |||
| ACLX | Arcellx, Inc. | 10%+ Owner | 20 Dec 2022 | |||
| GNCA | GENOCEA BIOSCIENCES, INC. | 10%+ Owner | 24 May 2022 |
Insider Transactions Reported by Forest Baskett:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.